MedPath

Comparative study of the efficacy and safety of intrathecal hyperbaric ropivacaine with hyperbaric bupivacaine in patients undergoing caesarean section under spinal anaesthesia

Phase 3
Completed
Conditions
Health Condition 1: 1- Obstetrics
Registration Number
CTRI/2023/06/054563
Lead Sponsor
Pt B D Sharma University of Health Sciences PGIMS Rohtak Haryana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Parturients between 20 to 35 years of age (American Society of Anaesthesiologists, ASA II) undergoing caesarean section under spinal anaesthesia

Exclusion Criteria

1Patient refusal

2 <18 years

3BMI > 35kg/m2

4Height < 5 feet

5Any contraindication to regional anesthesia

6Twin pregnancy

7Drug allergy to local anaesthetics/study drugs

8Refusal to give consent

9Conversion to general anesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the two drugs in terms of <br/ ><br>Onset of sensory and motor block. <br/ ><br>Duration of sensory and motor block.Timepoint: The segmental level of sensory block will be assessed by loss of sensation to pin-prick at 2 minute intervals for first 15 minutes and thereafter at 15 minute intervals till regression to L5. The motor block will be evaluated at similar time intervals using modified Bromage scale.
Secondary Outcome Measures
NameTimeMethod
To compare the maximum level of sensory block achieved <br/ ><br>To compare the frequency of adverse effects like hypotension, bradycardia, nausea, vomiting in both the groupsTimepoint: Time taken to achieve maximal level of sensory block will be noted in both groups <br/ ><br>Adverse effects like hypotension, bradycardia, nausea, vomiting, arrythmias, any episode of desaturation(spo2 less than 90%)
© Copyright 2025. All Rights Reserved by MedPath